Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP672506.RACsSXGrZ8crMAFwHNSp2RjZ4lCrjrmAwLGgI_DRcAFBk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP672506.RACsSXGrZ8crMAFwHNSp2RjZ4lCrjrmAwLGgI_DRcAFBk130_assertion type Assertion NP672506.RACsSXGrZ8crMAFwHNSp2RjZ4lCrjrmAwLGgI_DRcAFBk130_head.
- NP672506.RACsSXGrZ8crMAFwHNSp2RjZ4lCrjrmAwLGgI_DRcAFBk130_assertion description "[Forty-one consecutive children with acute lymphoblastic leukemia (ALL) received prophylaxis therapy with the low molecular weight heparin (LMWH) enoxaparin during L-asparaginase treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP672506.RACsSXGrZ8crMAFwHNSp2RjZ4lCrjrmAwLGgI_DRcAFBk130_provenance.
- NP672506.RACsSXGrZ8crMAFwHNSp2RjZ4lCrjrmAwLGgI_DRcAFBk130_assertion evidence source_evidence_literature NP672506.RACsSXGrZ8crMAFwHNSp2RjZ4lCrjrmAwLGgI_DRcAFBk130_provenance.
- NP672506.RACsSXGrZ8crMAFwHNSp2RjZ4lCrjrmAwLGgI_DRcAFBk130_assertion SIO_000772 11505079 NP672506.RACsSXGrZ8crMAFwHNSp2RjZ4lCrjrmAwLGgI_DRcAFBk130_provenance.
- NP672506.RACsSXGrZ8crMAFwHNSp2RjZ4lCrjrmAwLGgI_DRcAFBk130_assertion wasDerivedFrom befree-20140225 NP672506.RACsSXGrZ8crMAFwHNSp2RjZ4lCrjrmAwLGgI_DRcAFBk130_provenance.
- NP672506.RACsSXGrZ8crMAFwHNSp2RjZ4lCrjrmAwLGgI_DRcAFBk130_assertion wasGeneratedBy ECO_0000203 NP672506.RACsSXGrZ8crMAFwHNSp2RjZ4lCrjrmAwLGgI_DRcAFBk130_provenance.